Drug Profile
Prothrombin complex concentrate - Prothya BioSolutions
Alternative Names: CofactLatest Information Update: 30 Dec 2022
Price :
$50
*
At a glance
- Originator Sanquin Blood Supply Foundation
- Developer Prothya BioSolutions
- Class Blood coagulation factors
- Mechanism of Action Factor IX stimulants; Factor VII stimulants; Factor X stimulants; Prothrombin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Haemorrhage
Most Recent Events
- 09 Sep 2022 Prothya BioSolutions completes a phase I/II trial in Haemorrhage (In volunteers) in Netherlands and Czech Republic (IV) (EudraCT2021-004009-37)
- 05 Nov 2021 Phase-I/II clinical trials in Haemorrhage (In volunteers) in Netherlands (IV) (EudraCT2021-004009-37)
- 12 Nov 2007 Preregistration for Haemorrhage in European Union (IV)